An observational study in Preeclampsia, sponsored by Mohamed Sayed Abdelhafez. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 35 Years. Per ClinicalTrials.gov, last updated 2023-10-30.
Sponsored by Mohamed Sayed Abdelhafez · Observational
The purpose of this study is to determine the prevalence of positive antiphospholipid antibodies among women with preeclampsia and to determine the effect of antiphospholipid antibodies on the severity of preeclampsia and the obstetric outcomes
For all women included in the study, blood samples will be tested for anticardiolipin antibodies and lupus anticoagulant. The clinical details of all women will be collected by reviewing their hospital and prenatal records. The following clinical characteristics will be evaluated: maternal age, previous gestations, parity, past or family history of preeclampsia, gestational age at the onset of preeclampsia, gestational age at delivery and birth weight. The following pregnancy and delivery complications will be assessed: placental insufficiency, intrauterine growth restriction, fetal loss (stillbirth) and early neonatal death.
904 studies on the registry are indexed under Pre-Eclampsia; 240 are open to participants now.
This study's enrollment of 200 is above the median of 160 across 389 observational studies indexed under Pre-Eclampsia.
Browse Pre-Eclampsia studies →Mohamed Sayed Abdelhafez is the lead sponsor of 10 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Attendants of Tertiary Hospital Obstetric Outpateint Clinics and Emergency Department
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Testing for antiphospholipid antibodies (anticardiolipin antibodies and lupus anticoagulant) will be performed in pregnant women with preeclampsia.
Other: Testing for antiphospholipid antibodies
Blood samples will be tested for anticardiolipin antibodies and lupus anticoagulant
Rate of positive antiphospholipid antibodies
Number of women having positive antiphospholipid antibodies per total number of women
Time frame: 20 weeks to 42 weeks gestational age
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jan 2017 to primary completion in Dec 2019, 35 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mohamed Sayed Abdelhafez